T. Inokuchi et al., CHANGES IN CARNITINE METABOLISM WITH KETONE-BODY PRODUCTION IN OBESE GLUCOSE-INTOLERANT PATIENTS, Diabetes research and clinical practice, 30(1), 1995, pp. 1-7
To elucidate the relationship between carnitine metabolism and plasma
ketone body concentrations in moderately obese patients with mild gluc
ose intolerance, the ketone body and carnitine levels in the basal sta
te were determined in 72 obese patients: 20 with normal glucose tolera
nce (NGT), 29 with impaired glucose tolerance (IGT), and 23 with non-i
nsulin-dependent diabetes mellitus (NIDDM) having a fasting plasma glu
cose (FPG) level of less than 200 mg/dl. Total ketone body (TKB) level
s significantly (P < 0.05) increased in the order of NGT, IGT, NIDDM,
while the FPG and free fatty acid (FFA) concentrations were significan
tly (P < 0.05) higher in the NIDDM group than in the other two groups.
In contrast, the insulin, glucagon and glycerol levels were comparabl
e in the three groups. The plasma short-chain acylcarnitine (SCAC) con
centration and the acylcarnitine/free carnitine (AC/FC) ratio were sim
ilar in the IGT and NIDDM groups, and significantly (P < 0.05) greater
than those in the NGT group. The AC/FC ratio correlated significantly
with the FPG and FFA, but not with the TKB. These results suggest tha
t the combination of IGT with simple obesity may trigger the accelerat
ion of hepatic ketogenesis in conjunction with an elevated SCAC and an
increased AC/FC ratio. In addition, the data also imply that, in pati
ents with mild NIDDM, factors other than the carnitines may play a gre
ater role in enhancing ketonemia.